Do You Need Progesterone With Estrogen if You Still Have Your Uterus? Yes — Here’s the Whole Answer (2026)

Why is the answer such an unqualified yes?

Because this one was settled decades ago, in the most direct way medicine settles things: when estrogen-alone therapy was widely prescribed to women with a uterus in the 1970s, endometrial-cancer rates rose, the link was established, and adding a progestogen was shown to remove the excess risk. Every major guideline since builds on that: estrogen makes the endometrium proliferate; unopposed proliferation over time becomes hyperplasia and can become cancer; a progestogen opposes it.

The regulatory record mirrors the clinical one. The FDA’s November 2025 hormone-therapy labeling overhaul — which removed the WHI-era boxed warnings for cardiovascular disease, breast cancer, and dementia — explicitly retained the endometrial-cancer boxed warning for systemic estrogen-alone products. When an agency in the act of un-warning keeps exactly one warning, that tells you which risk survived scrutiny.

Why do you need progesterone with estrogen if you have a uterus?
Systemic estrogen alone stimulates the uterine lining, raising endometrial hyperplasia and cancer risk — a link established decades ago and reflected in the boxed warning the FDA kept on systemic estrogen-alone products even in its November 2025 labeling overhaul. A progestogen opposes that stimulation and removes the excess risk.

What counts as “a progestogen” — and which one is best?

“Progestogen” is the umbrella term for anything that does progesterone’s job on the endometrium. The main options a prescriber will choose among:

• Micronized progesterone — bioidentical, taken as a capsule (commonly at bedtime; drowsiness is a known effect many women use to their advantage). The option most DTC “bioidentical” programs pair by default.
• Synthetic progestins (e.g., medroxyprogesterone acetate, norethindrone) — the older class, effective at endometrial protection, sometimes chosen for cost or formulation reasons.
• Combination products — estrogen and progestogen manufactured together: combo patches, or the oral estradiol-plus-progesterone capsule (Bijuva) and similar FDA-approved combinations. One prescription, protection built in.
• Hormonal IUD — a levonorgestrel IUD delivers a progestogen directly to the uterus; clinicians use it for endometrial protection during estrogen therapy, which The Menopause Society’s 2022 position statement notes is an off-label use in the US — an option worth asking about if you already have one in place.

Which is “best” is genuinely individual — dosing schedule (continuous vs cyclic), sleep effects, bleeding patterns, cost, and personal history all move the answer. What is not individual is having one.

What are the progestogen options with estrogen therapy?
Micronized (bioidentical) progesterone capsules, synthetic progestins, FDA-approved combination products that build the progestogen in (combo patches, estradiol+progesterone capsules), and — used by clinicians for endometrial protection, which the 2022 Menopause Society statement notes is off-label for that purpose in the US — a levonorgestrel IUD. The right one is individual; having one is not.

What are the real exceptions?

• No uterus. After a hysterectomy there is no endometrium to protect, so estrogen-alone therapy is the standard — that’s exactly why estrogen-alone products exist. (Histories involving endometriosis or certain cancers can complicate this; that’s a prescriber conversation.)
• Low-dose vaginal estrogen. Creams, tablets, inserts, and rings for genitourinary symptoms act locally with minimal systemic absorption, and guidelines do not require a progestogen alongside them — consistent with the FDA’s November 2025 decision to remove the boxed warning from low-dose vaginal products specifically. The boundary to respect: this applies to low-dose vaginal products, not to systemic therapy delivered by any route.

A compounded cream marketed as “low-dose” is not automatically in the vaginal-estrogen category — compounded products aren’t FDA-reviewed, so their actual systemic absorption is the question to put to your prescriber. When in doubt, treat estrogen as systemic until a clinician tells you otherwise.

Do you need progesterone with vaginal estrogen?
Generally no — low-dose vaginal estrogen for genitourinary symptoms acts locally with minimal systemic absorption, and guidelines don’t require a progestogen with it (the FDA removed the boxed warning from these products in November 2025). The exception applies only to low-dose vaginal products, not to systemic estrogen by any route.

What actually happens if I skip the progesterone?

Nothing dramatic at first — which is exactly the trap. Unopposed systemic estrogen doesn’t announce itself; the endometrium thickens silently over months to years. The risk is dose- and duration-dependent: the longer and higher the unopposed exposure, the higher the likelihood of hyperplasia, which is why this isn’t a corner anyone should cut for convenience or because progesterone caused side effects that were never re-addressed.

If progesterone genuinely doesn’t agree with you — drowsiness beyond bedtime usefulness, mood effects, bloating — the guideline-aligned move is to change the progestogen, dose, or schedule with your prescriber, not to quietly drop it. And one symptom always overrides the schedule: unexpected vaginal bleeding on HRT warrants evaluation — usually benign, occasionally the early warning this whole rule exists to catch.

What happens if you take estrogen without progesterone with a uterus?
The uterine lining thickens silently; over months to years, unopposed systemic estrogen raises the risk of endometrial hyperplasia and cancer, dose- and duration-dependent. If a progestogen doesn’t agree with you, the fix is changing it with your prescriber — and any unexpected bleeding on HRT should be evaluated promptly.

How do the online HRT programs handle the progesterone rule?

A useful trust test for any HRT program is whether progestogen pairing is built into its offering. From RangeYourself’s verified registry (each fact from the provider’s own site, dates in the source strip; prices are per-product subscriptions unless noted — confirm at checkout):

• Winona — sells progesterone capsules (from $39/mo) and an estrogen+progesterone combination cream (from $89/mo) alongside its estrogen products; bioidentical-only lineup with compounded creams disclosed.
• Alloy — pairs progesterone from $23/mo with its estradiol products “when needed.”
• Hers — describes “estradiol pills or patches… plus oral progesterone when appropriate” (its menopause pricing is gated, so no verified dollar figure exists).
• Noom Menopause — prescribes FDA-approved progesterone pills alongside its estradiol patch and compounded bi-est cream.
• Sesame — lists progesterone (generic Prometrium) and combination estrogen/progestin products (Prempro, Bijuva, Mimvey) among its prescribable medications; subscription from $59/mo with meds separate.
• WeightWatchers Med+ Meno — lists oral progesterone tablets and combination estradiol+progesterone tablets among its FDA-approved MHT forms ($88/mo recurring tier; medication cost separate).
• MyMenopauseRx, Midi, Gennev, Elektra, Evernow, Wisp — clinic-model prescribers that send estrogen and progesterone to your pharmacy per an individualized plan.

What you’re checking for isn’t a specific brand — it’s that the program’s intake asks whether you have a uterus and its clinicians pair systemic estrogen accordingly. Every registry provider above offers a progestogen path; a program that doesn’t is missing the oldest safety rule in HRT.

Do online HRT programs include progesterone?
The verified ones pair it: Winona (progesterone from $39/mo, combo cream from $89/mo), Alloy (from $23/mo), Noom, Sesame, WeightWatchers, and Hers all describe progesterone or combination products alongside estrogen on their own sites, and clinic-model prescribers (Midi, MyMenopauseRx, Gennev, Elektra) handle pairing through your pharmacy. A program that doesn’t ask about your uterus is the red flag.